Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem Treatment
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
A prospective, open-label study investigated the pharmacokinetic profile of meropenem in
patients with post-neurosurgical central nervous system (CNS) infection, especially its BBB
penetration into cerebrospinal fluid (CSF).